Mapped: GLP-1s across the U.S.

Ohio saw a 6.9% increase in GLP-1 prescriptions last year, a lower number than the national average of 9.6%.

By the numbers: Nearly 1.7 million prescriptions were written for these medications in Ohio alone in 2024.

Between the lines: Officials in multiple states have warned consumers about unapproved versions of medications being sold as Ozempic, Wegovy, Mounjaro and Zepbound.